- 現金殖利率: N/A、總殖利率: 0、5年平均現金配發率: 40.82%
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
| EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 (10) | -0.58 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2022 (9) | -0.52 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2021 (8) | 0.30 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2020 (7) | -1.35 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2019 (6) | -0.40 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2018 (5) | 0.22 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2017 (4) | -0.92 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2016 (3) | 0.49 | 0 | 0.20 | 0 | 0.00 | 0 | 40.82 | 0 | 0.00 | 0 | 40.82 | 0 |
| EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 24Q3 (20) | -0.90 | -275.0 | -260.0 | -0.16 | 65.22 | 69.23 | -1.11 | -484.21 | -200.0 |
| 24Q2 (19) | -0.24 | -580.0 | -1100.0 | -0.46 | 4.17 | 39.47 | -0.19 | -480.0 | -58.33 |
| 24Q1 (18) | 0.05 | 122.73 | 150.0 | -0.48 | -442.86 | -152.63 | 0.05 | 108.62 | 150.0 |
| 23Q4 (17) | -0.22 | 12.0 | 35.29 | 0.14 | 126.92 | 800.0 | -0.58 | -56.76 | -11.54 |
| 23Q3 (16) | -0.25 | -1150.0 | 0.0 | -0.52 | 31.58 | 42.86 | -0.37 | -208.33 | -105.56 |
| 23Q2 (15) | -0.02 | 80.0 | -106.67 | -0.76 | -300.0 | -22.58 | -0.12 | -20.0 | -300.0 |
| 23Q1 (14) | -0.10 | 70.59 | 58.33 | -0.19 | -850.0 | 47.22 | -0.10 | 80.77 | 58.33 |
| 22Q4 (13) | -0.34 | -36.0 | -54.55 | -0.02 | 97.8 | 75.0 | -0.52 | -188.89 | -267.74 |
| 22Q3 (12) | -0.25 | -183.33 | -140.32 | -0.91 | -46.77 | -184.38 | -0.18 | -400.0 | -133.96 |
| 22Q2 (11) | 0.30 | 225.0 | 300.0 | -0.62 | -72.22 | -1450.0 | 0.06 | 125.0 | 175.0 |
| 22Q1 (10) | -0.24 | -9.09 | -442.86 | -0.36 | -350.0 | -1700.0 | -0.24 | -177.42 | -442.86 |
| 21Q4 (9) | -0.22 | -135.48 | 82.68 | -0.08 | 75.0 | 87.69 | 0.31 | -41.51 | 122.96 |
| 21Q3 (8) | 0.62 | 513.33 | 395.24 | -0.32 | -700.0 | -500.0 | 0.53 | 762.5 | 762.5 |
| 21Q2 (7) | -0.15 | -314.29 | -162.5 | -0.04 | -100.0 | -121.05 | -0.08 | -214.29 | -161.54 |
| 21Q1 (6) | 0.07 | 105.51 | 163.64 | -0.02 | 96.92 | 90.0 | 0.07 | 105.19 | 163.64 |
| 20Q4 (5) | -1.27 | -504.76 | -126.79 | -0.65 | -912.5 | -103.12 | -1.35 | -1587.5 | -237.5 |
| 20Q3 (4) | -0.21 | -187.5 | 0.0 | 0.08 | -57.89 | 0.0 | -0.08 | -161.54 | 0.0 |
| 20Q2 (3) | 0.24 | 318.18 | 0.0 | 0.19 | 195.0 | 0.0 | 0.13 | 218.18 | 0.0 |
| 20Q1 (2) | -0.11 | 80.36 | 0.0 | -0.20 | 37.5 | 0.0 | -0.11 | 72.5 | 0.0 |
| 19Q4 (1) | -0.56 | 0.0 | 0.0 | -0.32 | 0.0 | 0.0 | -0.40 | 0.0 | 0.0 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/10 | 5.27 | 0.75 | 16.59 | 49.85 | 20.13 | 15.6 | N/A | - | ||
| 2024/9 | 5.23 | 2.44 | 7.54 | 44.58 | 20.56 | 15.91 | 0.67 | - | ||
| 2024/8 | 5.1 | -8.51 | 12.45 | 39.35 | 22.53 | 15.49 | 0.69 | - | ||
| 2024/7 | 5.58 | 16.01 | 30.58 | 34.25 | 24.19 | 15.37 | 0.69 | - | ||
| 2024/6 | 4.81 | -3.62 | 16.58 | 28.67 | 23.02 | 15.1 | 0.71 | - | ||
| 2024/5 | 4.99 | -5.89 | 26.1 | 23.87 | 24.4 | 15.28 | 0.7 | - | ||
| 2024/4 | 5.3 | 6.15 | 35.36 | 18.88 | 23.96 | 14.08 | 0.76 | - | ||
| 2024/3 | 4.99 | 32.02 | 5.98 | 13.58 | 20.01 | 13.58 | 0.83 | - | ||
| 2024/2 | 3.78 | -21.25 | 16.28 | 8.59 | 30.03 | 12.55 | 0.9 | - | ||
| 2024/1 | 4.8 | 21.01 | 43.37 | 4.8 | 43.37 | 13.66 | 0.82 | - | ||
| 2023/12 | 3.97 | -18.78 | 27.86 | 50.41 | 20.61 | 13.37 | 0.77 | - | ||
| 2023/11 | 4.89 | 8.18 | 49.09 | 46.44 | 20.03 | 14.25 | 0.72 | - | ||
| 2023/10 | 4.52 | -6.77 | 25.18 | 41.55 | 17.34 | 13.9 | 0.74 | - | ||
| 2023/9 | 4.84 | 6.77 | 34.51 | 37.04 | 16.45 | 13.65 | 0.66 | - | ||
| 2023/8 | 4.54 | 6.22 | 64.63 | 32.19 | 14.14 | 13.01 | 0.69 | 因中國地區2022年疫情嚴峻導致工廠停工,客戶出貨延期,則2023年恢復正常供應,另因今年美元匯率升值,故因此導致營收與去年有所差異 | ||
| 2023/7 | 4.27 | 1.69 | 46.59 | 27.66 | 8.67 | 12.43 | 0.72 | - | ||
| 2023/6 | 4.2 | 6.17 | 19.42 | 23.38 | 3.77 | 12.07 | 0.77 | - | ||
| 2023/5 | 3.96 | 1.01 | -8.95 | 19.19 | 0.88 | 12.58 | 0.74 | - | ||
| 2023/4 | 3.92 | -16.88 | 15.76 | 15.23 | 3.79 | 11.88 | 0.78 | - | ||
| 2023/3 | 4.71 | 44.85 | 7.26 | 11.31 | 0.2 | 11.31 | 0.91 | - | ||
| 2023/2 | 3.25 | -2.91 | 29.09 | 6.6 | -4.28 | 9.71 | 1.06 | - | ||
| 2023/1 | 3.35 | 7.93 | -23.49 | 3.35 | -23.49 | 9.73 | 1.06 | - | ||
| 2022/12 | 3.1 | -5.29 | -16.36 | 41.79 | -9.29 | 9.99 | 0.97 | - | ||
| 2022/11 | 3.28 | -9.16 | -17.45 | 38.69 | -8.68 | 10.49 | 0.93 | - | ||
| 2022/10 | 3.61 | 0.17 | -2.27 | 35.41 | -7.77 | 9.97 | 0.97 | - | ||
| 2022/9 | 3.6 | 30.68 | -17.53 | 31.8 | -8.35 | 9.27 | 1.12 | - | ||
| 2022/8 | 2.76 | -5.41 | -23.71 | 28.2 | -7.03 | 9.19 | 1.13 | - | ||
| 2022/7 | 2.91 | -17.14 | -18.32 | 25.45 | -4.78 | 10.77 | 0.96 | - | ||
| 2022/6 | 3.52 | -19.05 | -10.25 | 22.53 | -2.69 | 11.24 | 0.91 | - | ||
| 2022/5 | 4.34 | 28.43 | 25.83 | 19.02 | -1.15 | 12.12 | 0.85 | - | ||
| 2022/4 | 3.38 | -22.98 | -24.54 | 14.67 | -7.06 | 10.29 | 1.0 | - | ||
| 2022/3 | 4.39 | 74.33 | 17.54 | 11.29 | -0.12 | 11.29 | 0.87 | - | ||
| 2022/2 | 2.52 | -42.46 | -25.52 | 6.9 | -8.85 | 10.61 | 0.92 | - | ||
| 2022/1 | 4.38 | 17.99 | 4.61 | 4.38 | 4.61 | 12.06 | 0.81 | - | ||
| 2021/12 | 3.71 | -6.52 | 0.98 | 46.08 | 8.08 | 11.37 | 0.8 | - | ||
| 2021/11 | 3.97 | 7.53 | 5.31 | 42.37 | 8.75 | 12.03 | 0.76 | - | ||
| 2021/10 | 3.69 | -15.46 | -2.03 | 38.4 | 9.12 | 11.67 | 0.78 | - | ||
| 2021/9 | 4.37 | 20.89 | 17.85 | 34.71 | 10.45 | 11.55 | 0.79 | - | ||
| 2021/8 | 3.61 | 1.26 | -4.13 | 30.34 | 9.47 | 11.1 | 0.82 | - | ||
| 2021/7 | 3.57 | -8.96 | 0.95 | 26.73 | 11.61 | 10.94 | 0.84 | - | ||
| 2021/6 | 3.92 | 13.49 | 2.11 | 23.16 | 13.45 | 11.85 | 0.85 | - | ||
| 2021/5 | 3.45 | -22.98 | -14.86 | 19.24 | 16.08 | 11.67 | 0.87 | - | ||
| 2021/4 | 4.48 | 19.97 | -7.05 | 15.79 | 26.1 | 11.6 | 0.87 | - | ||
| 2021/3 | 3.74 | 10.46 | -2.16 | 11.3 | 46.88 | 11.3 | 0.87 | - | ||
| 2021/2 | 3.38 | -19.18 | 144.26 | 7.57 | 95.2 | 11.24 | 0.88 | COVID-19影響增加筆電銷售量 | ||
| 2021/1 | 4.19 | 13.89 | 67.94 | 4.19 | 67.94 | 11.63 | 0.85 | COVID-19影響增加筆電銷售量 | ||
| 2020/12 | 3.67 | -2.52 | 35.34 | 42.63 | 24.88 | 11.21 | 0.77 | - | ||
| 2020/11 | 3.77 | 0.03 | 31.0 | 38.96 | 23.98 | 11.24 | 0.77 | - | ||
| 2020/10 | 3.77 | 1.69 | 19.34 | 35.19 | 23.27 | 11.24 | 0.77 | - | ||
| 2020/9 | 3.71 | -1.65 | 21.37 | 31.42 | 23.76 | 11.01 | 0.69 | - | ||
| 2020/8 | 3.77 | 6.63 | 12.88 | 27.71 | 24.09 | 11.14 | 0.69 | - | ||
| 2020/7 | 3.53 | -7.91 | 8.38 | 23.95 | 26.06 | 11.43 | 0.67 | - | ||
| 2020/6 | 3.84 | -5.37 | 27.99 | 20.41 | 29.72 | 12.72 | 0.5 | - | ||
| 2020/5 | 4.06 | -15.91 | 31.61 | 16.57 | 30.13 | 12.7 | 0.5 | - | ||
| 2020/4 | 4.82 | 26.28 | 87.04 | 12.52 | 29.65 | 10.03 | 0.63 | 因應疫情而實施遠距管理或教學，使筆電需求增加，另新事業產品營收增加 | ||
| 2020/3 | 3.82 | 175.79 | 39.74 | 7.7 | 8.75 | 7.7 | 0.92 | 因武漢肺炎延至本月出貨 | ||
| 2020/2 | 1.38 | -44.43 | -21.61 | 3.88 | -10.75 | 6.59 | 1.08 | - | ||
| 2020/1 | 2.49 | -8.2 | -3.3 | 2.49 | -3.3 | 8.09 | 0.88 | - | ||
| 2019/12 | 2.72 | -5.64 | 26.07 | 34.14 | 11.04 | 0.0 | N/A | - | ||
| 2019/11 | 2.88 | -8.86 | -5.05 | 31.42 | 9.91 | 0.0 | N/A | - |
